Gary Dukart

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

Michael B. Atkins, Manuel Hidalgo, Walter M. Stadler et al. · Journal of Clinical Oncology · 2004 · 943 citations · Full text

Urology, Advanced Rcc Patients, Genitourinary Cancer +15

Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose

Keith A. Rodvold, Mark H. Gotfried, Mary Cwik et al. · Journal of Antimicrobial Chemotherapy · 2006 · 300 citations

Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia

Antonio Freire, Vasyl Melnyk, Min Ja Kim et al. · Diagnostic Microbiology and Infectious Disease · 2010 · 283 citations

Health Sciences, Antibiotics, Healthcare-associated Infection +8

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.

I. Craig Henderson, Joseph C. Allegra, Thomas Woodcock et al. · Journal of Clinical Oncology · 1989 · 247 citations

Randomized Clinical Trial, Metastatic Breast Cancer, Breast Oncology +11

A Phase I and Pharmacokinetic Study of Temsirolimus (CCI-779) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients with Advanced Cancer

Manuel Hidalgo, Jan C. Buckner, Charles Erlichman et al. · Clinical Cancer Research · 2006 · 209 citations